Where Will C3.ai Stock Be in 1 Year?
C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…
Sell
22
LABD Quote, Financials, Valuation and Earnings
Last price:
$6.39
Seasonality move
:
2.86%
Day range:
$6.22 - $6.47
52-week range:
$4.78 - $16.05
Dividend yield:
4.32%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
14M
Avg. volume:
14M
1-year change:
3.4%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -- | -- | -- | -- |
|
DRIP
Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs
|
-- | -- | -- | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -- | -- | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -- | -- | -- | -- |
|
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
|
-- | -- | -- | -- | -- |
|
TECS
Direxion Daily Technology Bear 3x Shares
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
$6.39 | -- | -- | -- | $0.04 | 4.32% | -- |
|
DRIP
Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs
|
$8.73 | -- | -- | -- | $0.06 | 3.72% | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
$25.10 | -- | -- | -- | $0.20 | 4.14% | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
$5.41 | -- | -- | -- | $0.06 | 5.57% | -- |
|
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
|
$8.40 | -- | -- | -- | $0.08 | 8.35% | -- |
|
TECS
Direxion Daily Technology Bear 3x Shares
|
$26.01 | -- | -- | -- | $0.17 | 6.4% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -3.529 | -- | -- |
|
DRIP
Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs
|
-- | -2.064 | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -2.524 | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -1.436 | -- | -- |
|
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
|
-- | -5.638 | -- | -- |
|
TECS
Direxion Daily Technology Bear 3x Shares
|
-- | -3.957 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LABD
Direxion Daily S&P Biotech Bear 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
DRIP
Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs
|
-- | -- | -- | -- | -- | -- |
|
DRV
Direxion Daily Real Estate Bear 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
EDZ
Direxion Daily MSCI Emerging Markets Bear 3x Shs
|
-- | -- | -- | -- | -- | -- |
|
HIBS
Direxion Daily S&P 500 High Beta Bear 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
TECS
Direxion Daily Technology Bear 3x Shares
|
-- | -- | -- | -- | -- | -- |
Direxion Daily S&P Biotech Bear 3X Shares vs. Competitors
-
Which has Higher Returns LABD or DRIP?
Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- DRIPDirexion Daily S&P Oil & Gas Exp & Prod Br 2X Shs-- -- -- -
What do Analysts Say About LABD or DRIP?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 DRIPDirexion Daily S&P Oil & Gas Exp & Prod Br 2X Shs0 0 0 -
Is LABD or DRIP More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.722, which suggesting that the stock is 372.249% less volatile than S&P 500. In comparison Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs has a beta of -1.965, suggesting its less volatile than the S&P 500 by 296.505%.
-
Which is a Better Dividend Stock LABD or DRIP?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.04 per share corresponding to a yield of 4.32%. Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs offers a yield of 3.72% to investors and pays a quarterly dividend of $0.06 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or DRIP?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily S&P Oil & Gas Exp & Prod Br 2X Shs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- DRIPDirexion Daily S&P Oil & Gas Exp & Prod Br 2X Shs-- -- -- --
-
Which has Higher Returns LABD or DRV?
Direxion Daily Real Estate Bear 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Real Estate Bear 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- DRVDirexion Daily Real Estate Bear 3X Shares-- -- -- -
What do Analysts Say About LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Real Estate Bear 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Real Estate Bear 3X Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Real Estate Bear 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 DRVDirexion Daily Real Estate Bear 3X Shares0 0 0 -
Is LABD or DRV More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.722, which suggesting that the stock is 372.249% less volatile than S&P 500. In comparison Direxion Daily Real Estate Bear 3X Shares has a beta of -3.144, suggesting its less volatile than the S&P 500 by 414.413%.
-
Which is a Better Dividend Stock LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.04 per share corresponding to a yield of 4.32%. Direxion Daily Real Estate Bear 3X Shares offers a yield of 4.14% to investors and pays a quarterly dividend of $0.20 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Real Estate Bear 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or DRV?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Real Estate Bear 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Real Estate Bear 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Real Estate Bear 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Real Estate Bear 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- DRVDirexion Daily Real Estate Bear 3X Shares-- -- -- --
-
Which has Higher Returns LABD or EDZ?
Direxion Daily MSCI Emerging Markets Bear 3x Shs has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily MSCI Emerging Markets Bear 3x Shs's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs-- -- -- -
What do Analysts Say About LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily MSCI Emerging Markets Bear 3x Shs has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily MSCI Emerging Markets Bear 3x Shs, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily MSCI Emerging Markets Bear 3x Shs.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs0 0 0 -
Is LABD or EDZ More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.722, which suggesting that the stock is 372.249% less volatile than S&P 500. In comparison Direxion Daily MSCI Emerging Markets Bear 3x Shs has a beta of -2.348, suggesting its less volatile than the S&P 500 by 334.817%.
-
Which is a Better Dividend Stock LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.04 per share corresponding to a yield of 4.32%. Direxion Daily MSCI Emerging Markets Bear 3x Shs offers a yield of 5.57% to investors and pays a quarterly dividend of $0.06 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily MSCI Emerging Markets Bear 3x Shs pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or EDZ?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily MSCI Emerging Markets Bear 3x Shs quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily MSCI Emerging Markets Bear 3x Shs's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily MSCI Emerging Markets Bear 3x Shs's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily MSCI Emerging Markets Bear 3x Shs. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- EDZDirexion Daily MSCI Emerging Markets Bear 3x Shs-- -- -- --
-
Which has Higher Returns LABD or HIBS?
Direxion Daily S&P 500 High Beta Bear 3X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily S&P 500 High Beta Bear 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- HIBSDirexion Daily S&P 500 High Beta Bear 3X Shares-- -- -- -
What do Analysts Say About LABD or HIBS?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily S&P 500 High Beta Bear 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily S&P 500 High Beta Bear 3X Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily S&P 500 High Beta Bear 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 HIBSDirexion Daily S&P 500 High Beta Bear 3X Shares0 0 0 -
Is LABD or HIBS More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.722, which suggesting that the stock is 372.249% less volatile than S&P 500. In comparison Direxion Daily S&P 500 High Beta Bear 3X Shares has a beta of -4.277, suggesting its less volatile than the S&P 500 by 527.696%.
-
Which is a Better Dividend Stock LABD or HIBS?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.04 per share corresponding to a yield of 4.32%. Direxion Daily S&P 500 High Beta Bear 3X Shares offers a yield of 8.35% to investors and pays a quarterly dividend of $0.08 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily S&P 500 High Beta Bear 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or HIBS?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily S&P 500 High Beta Bear 3X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily S&P 500 High Beta Bear 3X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily S&P 500 High Beta Bear 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily S&P 500 High Beta Bear 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- HIBSDirexion Daily S&P 500 High Beta Bear 3X Shares-- -- -- --
-
Which has Higher Returns LABD or TECS?
Direxion Daily Technology Bear 3x Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bear 3X Shares's net margin of --. Direxion Daily S&P Biotech Bear 3X Shares's return on equity of -- beat Direxion Daily Technology Bear 3x Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- TECSDirexion Daily Technology Bear 3x Shares-- -- -- -
What do Analysts Say About LABD or TECS?
Direxion Daily S&P Biotech Bear 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Technology Bear 3x Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bear 3X Shares has higher upside potential than Direxion Daily Technology Bear 3x Shares, analysts believe Direxion Daily S&P Biotech Bear 3X Shares is more attractive than Direxion Daily Technology Bear 3x Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABDDirexion Daily S&P Biotech Bear 3X Shares0 0 0 TECSDirexion Daily Technology Bear 3x Shares0 0 0 -
Is LABD or TECS More Risky?
Direxion Daily S&P Biotech Bear 3X Shares has a beta of -2.722, which suggesting that the stock is 372.249% less volatile than S&P 500. In comparison Direxion Daily Technology Bear 3x Shares has a beta of -3.509, suggesting its less volatile than the S&P 500 by 450.892%.
-
Which is a Better Dividend Stock LABD or TECS?
Direxion Daily S&P Biotech Bear 3X Shares has a quarterly dividend of $0.04 per share corresponding to a yield of 4.32%. Direxion Daily Technology Bear 3x Shares offers a yield of 6.4% to investors and pays a quarterly dividend of $0.17 per share. Direxion Daily S&P Biotech Bear 3X Shares pays -- of its earnings as a dividend. Direxion Daily Technology Bear 3x Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABD or TECS?
Direxion Daily S&P Biotech Bear 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Technology Bear 3x Shares quarterly revenues of --. Direxion Daily S&P Biotech Bear 3X Shares's net income of -- is lower than Direxion Daily Technology Bear 3x Shares's net income of --. Notably, Direxion Daily S&P Biotech Bear 3X Shares's price-to-earnings ratio is -- while Direxion Daily Technology Bear 3x Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bear 3X Shares is -- versus -- for Direxion Daily Technology Bear 3x Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABDDirexion Daily S&P Biotech Bear 3X Shares-- -- -- -- TECSDirexion Daily Technology Bear 3x Shares-- -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is the Ceiling for IONQ Stock?
IonQ (NYSE:IONQ) is a quantum computing startup that, like many…
Can FUBO Stock Double?
TV streaming service Fubo (NYSE:FUBO) has seen incredible returns so…
Stock Ideas
Buy
69
Is NVDA Stock a Buy?
Market Cap: $4T
P/E Ratio: 56x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 43x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
58
INKT alert for Jul 12
MiNK Therapeutics [INKT] is up 727.94% over the past day.
Buy
51
NEGG alert for Jul 12
Newegg Commerce [NEGG] is up 74.03% over the past day.
Buy
68
ATRO alert for Jul 12
Astronics [ATRO] is up 16.28% over the past day.
